Reduction of Nonspecificity Motifs in Synthetic Antibody Libraries

被引:42
作者
Kelly, Ryan L. [1 ]
Le, Doris [2 ]
Zhao, Jessie [2 ]
Wittrup, K. Dane [1 ,2 ]
机构
[1] MIT, Dept Biol, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02142 USA
[2] MIT, Dept Chem Engn, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA
关键词
nonspecificity; monoclonal antibody; synthetic scFv library; complementarity-determining region; cross-interaction; YEAST SURFACE DISPLAY; SELF-ASSOCIATION; AFFINITY MATURATION; ANTIGEN RECOGNITION; VARIABLE REGION; CLEARANCE; DIVERSITY; BINDING; PHARMACOKINETICS; AGGREGATION;
D O I
10.1016/j.jmb.2017.11.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Successful antibody development requires both functional binding and desirable biophysical characteristics. In the current study, we analyze the causes of one hurdle to clinical development, off-target reactivity, or nonspecificity. We used a high-throughput nonspecificity assay to isolate panels of nonspecific antibodies from two synthetic single-chain variable fragment libraries expressed on the surface of yeast, identifying both individual amino acids and motifs within the complementarity-determining regions which contribute to the phenotype. We find enrichment of glycine, valine, and arginine as both individual amino acids and as a part of motifs, and additionally enrichment of motifs containing tryptophan. Insertion of any of these motifs into the complementarity-determining region H3 of a "clean" antibody increased its nonspecificity, with greatest increases in antibodies containing Trp or Val motifs. We next applied these rules to the creation of a synthetic diversity library based on natural frameworks with significantly decreased incorporation of such motifs and demonstrated its ability to isolate binders to a wide panel of antigens. This work both provides a greater understanding of the drivers of nonspecificity and provides design rules to increase efficiency in the isolation of antibodies with drug-like properties. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:119 / 130
页数:12
相关论文
共 42 条
[1]   Aggregation in Protein-Based Biotherapeutics: Computational Studies and Tools to Identify Aggregation-Prone Regions [J].
Agrawal, Neeraj J. ;
Kumar, Sandeep ;
Wang, Xiaoling ;
Helk, Bernhard ;
Singh, Satish K. ;
Trout, Bernhardt L. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (12) :5081-5095
[2]   DREME: motif discovery in transcription factor ChIP-seq data [J].
Bailey, Timothy L. .
BIOINFORMATICS, 2011, 27 (12) :1653-1659
[3]   The intrinsic contributions of tyrosine, serine, glycine and arginine to the affinity and specificity of antibodies [J].
Birtalan, Sara ;
Zhang, Yingnan ;
Fellouse, Frederic A. ;
Shao, Lihua ;
Schaefer, Gabriele ;
Sidhu, Sachdev S. .
JOURNAL OF MOLECULAR BIOLOGY, 2008, 377 (05) :1518-1528
[4]   The functional capacity of the natural amino acids for molecular recognition [J].
Birtalan, Sara ;
Fisher, Robert D. ;
Sidhu, Sachdev S. .
MOLECULAR BIOSYSTEMS, 2010, 6 (07) :1186-1194
[5]   Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics [J].
Boswell, C. Andrew ;
Tesar, Devin B. ;
Mukhyala, Kiran ;
Theil, Frank-Peter ;
Fielder, Paul J. ;
Khawli, Leslie A. .
BIOCONJUGATE CHEMISTRY, 2010, 21 (12) :2153-2163
[6]   Isolating and engineering human antibodies using yeast surface display [J].
Chao, Ginger ;
Lau, Wai L. ;
Hackel, Benjamin J. ;
Sazinsky, Stephen L. ;
Lippow, Shaun M. ;
Wittrup, K. Dane .
NATURE PROTOCOLS, 2006, 1 (02) :755-768
[7]   Rational Design of Biobetters with Enhanced Stability [J].
Courtois, Fabienne ;
Schneider, Curtiss P. ;
Agrawal, Neeraj J. ;
Trout, Bernhardt L. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 104 (08) :2433-2440
[8]   The interplay of non-specific binding, target-mediated clearance and FcRn interactions on the pharmacokinetics of humanized antibodies [J].
Datta-Mannan, Amita ;
Lu, Jirong ;
Witcher, Derrick R. ;
Leung, Donmienne ;
Tang, Ying ;
Wroblewski, Victor J. .
MABS, 2015, 7 (06) :1084-1093
[9]   Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics [J].
Datta-Mannan, Amita ;
Thangaraju, Arunkumar ;
Leung, Donmienne ;
Tang, Ying ;
Witcher, Derrick R. ;
Lu, Jirong ;
Wroblewski, Victor J. .
MABS, 2015, 7 (03) :483-493
[10]   Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo [J].
Dobson, Claire L. ;
Devine, Paul W. A. ;
Phillips, Jonathan J. ;
Higazi, Daniel R. ;
Lloyd, Christopher ;
Popovic, Bojana ;
Arnold, Joanne ;
Buchanan, Andrew ;
Lewis, Arthur ;
Goodman, Joanne ;
van der Walle, Christopher F. ;
Thornton, Peter ;
Vinall, Lisa ;
Lowne, David ;
Aagaard, Anna ;
Olsson, Lise-Lotte ;
Wollberg, Anna Ridderstad ;
Welsh, Fraser ;
Karamanos, Theodoros K. ;
Pashley, Clare L. ;
Iadanza, Matthew G. ;
Ranson, Neil A. ;
Ashcroft, Alison E. ;
Kippen, Alistair D. ;
Vaughan, Tristan J. ;
Radford, Sheena E. ;
Lowe, David C. .
SCIENTIFIC REPORTS, 2016, 6